Targeting Epigenetics in Cancer Therapy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 25 July 2024 | Viewed by 77
Special Issue Editor
Special Issue Information
Dear Colleagues,
Despite the foundational role of chemotherapy in cancer treatment, epigenetic therapy also has a significant impact as a monotherapy or combined therapy. Epigenetic therapy relies on the reversible nature of epigenetic modifications, which establish dynamic shifts between active and suppressed transcriptional states. A myriad of enzymes are involved in establishing the dynamic epigenetic changes and each could represent a potential target in cancer treatment. Currently, histone deacetylase (HDAC) inhibitors and DNA methyltransferase (DNMT) inhibitors are approved for use in specific hematologic malignancies.
In this Special Issue, we aim to identify novel epigenetic targets and epigenetic modifiers that could have potential in cancer therapeutics. We are also interested in understanding the molecular basis of existing epigenetic therapies and the expansion of their clinical utility in different types of cancer. Finally, the role of herbal medicine in reversing epigenetic changes, with the consequent induction of tumor arrest and apoptosis of cancer cells, is also an aim of this Special Issue. It is worth mentioning that pure clinical studies will not be suitable for submission in this issue and only clinical or pure model submissions with biomolecular experiments are welcome.
Dr. Tamer E. Fandy
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- epigenetic therapy
- histone acetylation
- histone modifications
- DNA methylation
- DNA methyltransferase inhibitors
- histone deacetylase inhibitors
- histone methylation
- miRNA modifications
- herbal products
